US2001003423A1PendingUtilityA1
Magnetic resonance imaging
Priority: Mar 9, 1998Filed: Jan 30, 2001Published: Jun 14, 2001
Est. expiryMar 9, 2018(expired)· nominal 20-yr term from priority
Inventors:Lawrence L. Wald
G01R 33/485G01R 33/5607G01R 33/4838
37
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods for imaging the distribution of a marker compound in a sample using magnetic resonance imaging.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for imaging the distribution of n-acetylaspartic acid (NAA) in mammalian neuronal tissue, said method comprising:
a) exciting said neuronal tissue to generate magnetic resonance signals, including signals corresponding to NAA; and b) suppressing non-NAA magnetic resonance signals by a combination of band selective inversion with gradient dephasing, and chemical shift selective pre-excitation and dephasing.
2 . A method of claim 1 , wherein said suppressing step (b) suppresses magnetic resonances down field from 2.5 ppm.
3 . A method of claim 2 , wherein said chemical shift selective pre-excitation includes an excitation bandwidth of about 1.8 ppm to 2.5 ppm, said bandwidth including the water resonance.
4 . A method of claim 2 , wherein said band selective inversion includes an excitation bandwidth of about 1.8 ppm to 2.5 ppm, and said dephasing produces a suppression band which includes the water resonance at about 4.7 ppm, the choline resonance at about 3.2 ppm, and the phosphocreatine resonance at about 3.0 ppm.
5 . A method of claim 1 , further comprising, after the suppressing step (b), the step (c) of encoding the NAA signal with readout and phase encode gradients.
6 . A method of claim 5 , further comprising, after the encoding step (c), the step (d) of reconstructing the image using two-dimensional Fourier transformation to obtain a NAA weighted image.
7 . A method of claim 5 , wherein the encoding step (c) has a minimum imaging time of 96 seconds for a spatial encoding matrix of at least 256×64.
8 . A method of claim 5 , wherein the encoding step (c) has a minimum imaging time of between 30 and 260 seconds for a spatial encoding matrix of 256×256.
9 . A method of claim 1 , wherein said exciting step includes slice selective spin-echo excitation.
10 . A method of claim 1 , wherein said exciting step (a) includes volume selective double spin-echo excitation.
11 . A method of claim 10 , wherein said volume selective double spin-echo excitation includes orthogonal slice selection pulses in a double spin echo configuration (90°-180°-180°).
12 . A method of claim 11 , wherein said volume selective double spin-echo excitation includes a STEAM localization configuration (90°-90°-90°).
13 . A method for imaging the distribution of a marker compound selected from n-acetyl aspartic acid, citrate, choline, phosphocreatine, and lactate in mammalian tissue, said method comprising:
i) exciting said tissue to generate magnetic resonance signals, including signals corresponding to said marker compound, ii) suppressing non-marker compound magnetic resonance signals using band selective inversion with gradient dephasing and chemical shift selective pre-excitation, and iii) encoding the remaining marker compound signal using conventional readout and phase encoding gradients.
14 . A method of claim 13 , wherein said tissue is prostate tissue and said marker is citrate.
15 . A method of claim 13 , wherein said marker is lactate, choline, or phosphocreatine.
16 . A method of claim 13 , wherein said tissue is neuronal tissue and said marker is n-acetyl aspartic acid, choline, or phosphocreatine.Join the waitlist — get patent alerts
Track US2001003423A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.